Literature DB >> 18773308

Translational applications of antibody phage display.

Don L Siegel1.   

Abstract

Recent developments in molecular immunology have facilitated the expression of immune repertoires in the form of immunoglobulin fragments on the surface of filamentous bacteriophage. Such approaches, known as "phage display", have provided powerful tools for producing monoclonal antibodies for research, clinical, and therapeutic applications. Our laboratory has combined these techniques with novel selection methods to isolate extraordinarily large arrays of human antibodies that can be used for developing new diagnostic reagents and methods for their use, as well as reagents that may serve as leads for the design of novel therapeutic molecules. In particular, application of phage display to the study of antibody-mediated autoimmune disease, notably idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, and pemphigus have facilitated comprehensive genetic and serologic analyses of pathogenic autoantibodies thereby offering new insights into disease pathophysiology and approaches for their treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773308     DOI: 10.1007/s12026-008-8044-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  21 in total

Review 1.  Research and clinical applications of antibody phage display in transfusion medicine.

Authors:  D L Siegel
Journal:  Transfus Med Rev       Date:  2001-01

Review 2.  Immune thrombocytopenic purpura.

Authors:  Douglas B Cines; Victor S Blanchette
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

Review 3.  On the mechanism of staphylococcal protein A immunomodulation.

Authors:  Gregg J Silverman; Carl S Goodyear; Don L Siegel
Journal:  Transfusion       Date:  2005-02       Impact factor: 3.157

4.  Temporal and dose-dependent relationships between in vivo B cell receptor-targeted proliferation and deletion-induced by a microbial B cell toxin.

Authors:  Carl S Goodyear; Fujimi Sugiyama; Gregg J Silverman
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

Review 5.  The human immune response to red blood cell antigens as revealed by repertoire cloning.

Authors:  D L Siegel
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology.

Authors:  D L Siegel; T Y Chang; S L Russell; V Y Bunya
Journal:  J Immunol Methods       Date:  1997-08-07       Impact factor: 2.303

7.  A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.

Authors:  D R Burton; C F Barbas; M A Persson; S Koenig; R M Chanock; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies.

Authors:  Ken Ishii; Chenyan Lin; Don L Siegel; John R Stanley
Journal:  J Invest Dermatol       Date:  2007-11-15       Impact factor: 8.551

9.  Targeting pemphigus autoantibodies through their heavy-chain variable region genes.

Authors:  Aimee S Payne; Don L Siegel; John R Stanley
Journal:  J Invest Dermatol       Date:  2007-03-29       Impact factor: 8.551

10.  Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning.

Authors:  M A Persson; R H Caothien; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

View more
  8 in total

Review 1.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

Review 2.  Systems approaches to design of targeted therapeutic delivery.

Authors:  Jacob W Myerson; Jacob S Brenner; Colin F Greineder; Vladimir R Muzykantov
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-05-06

3.  Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.

Authors:  Adnan Memic; Veronica V Volgina; Hélène A Gussin; David R Pepperberg; Brian K Kay
Journal:  J Immunol Methods       Date:  2011-02-26       Impact factor: 2.303

4.  Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.

Authors:  Aizhi Zhao; Selene Nunez-Cruz; Chunsheng Li; George Coukos; Don L Siegel; Nathalie Scholler
Journal:  J Immunol Methods       Date:  2010-09-15       Impact factor: 2.303

5.  Proteomic Analysis of Pemphigus Autoantibodies Indicates a Larger, More Diverse, and More Dynamic Repertoire than Determined by B Cell Genetics.

Authors:  Jing Chen; Qi Zheng; Christoph M Hammers; Christoph T Ellebrecht; Eric M Mukherjee; Hsin-Yao Tang; Chenyan Lin; Huijie Yuan; Meng Pan; Jana Langenhan; Lars Komorowski; Don L Siegel; Aimee S Payne; John R Stanley
Journal:  Cell Rep       Date:  2017-01-03       Impact factor: 9.423

Review 6.  Immunogenicity of therapeutic recombinant immunotoxins.

Authors:  Ronit Mazor; Masanori Onda; Ira Pastan
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 10.983

7.  Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library.

Authors:  Yonghai Li; Donald L Siegel; Nathalie Scholler; David E Kaplan
Journal:  BMC Biotechnol       Date:  2012-05-07       Impact factor: 2.563

8.  Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis.

Authors:  Seraina Cooksley-Decasper; Hans Reiser; Daniela S Thommen; Barbara Biedermann; Michel Neidhart; Joanna Gawinecka; Gieri Cathomas; Fabian C Franzeck; Christophe Wyss; Roland Klingenberg; Paolo Nanni; Bernd Roschitzki; Christian Matter; Petra Wolint; Maximilian Y Emmert; Marc Husmann; Beatrice Amann-Vesti; Wilibald Maier; Steffen Gay; Thomas F Lüscher; Arnold von Eckardstein; Danielle Hof
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.